OPKO Health, Inc. Increase (Decrease) in Contract with Customer, Liability
OPKO Health, Inc. (OPK) reported Increase (Decrease) in Contract with Customer, Liability of $44.95 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-11-07
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-09-30 was $44.95M.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-06-30 was $0.00.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $1.24M.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$131.00K.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$329.00K.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$15.91M.
- OPKO Health, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was -$5.39M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $44.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $44.95M derived: sum of 2 quarters · filed 2024-11-07 | $44.95M 10-Q · filed 2024-11-07 | $46.20M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $1.24M derived: sum of 3 quarters · filed 2024-08-07 | -$133.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 | $1.24M derived: sum of 2 quarters · filed 2024-05-07 | -$133.00K derived: sum of 3 quarters · filed 2024-11-07 | -$133.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$133.00K derived: sum of 2 quarters · filed 2024-11-07 | -$133.00K derived: sum of 3 quarters · filed 2024-11-07 | -$131.00K 10-K · filed 2024-03-01 | |
| 2023-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.38M derived: sum of 2 quarters · filed 2024-11-07 | -$1.37M 10-Q · filed 2024-11-07 | -$2.00K 10-Q · filed 2023-11-06 | -$1.63M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.00K 10-Q · filed 2024-08-07 | -$254.00K derived: sum of 3 quarters · filed 2024-08-07 | -$310.00K derived: sum of 4 quarters · filed 2024-08-07 | |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-07 | -$254.00K derived: sum of 2 quarters · filed 2024-05-07 | -$310.00K derived: sum of 3 quarters · filed 2024-05-07 | -$323.00K derived: sum of 4 quarters · filed 2024-05-07 | |
| 2022-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$312.00K derived: sum of 2 quarters · filed 2024-03-01 | -$325.00K derived: sum of 3 quarters · filed 2024-03-01 | -$329.00K 10-K · filed 2024-03-01 | |
| 2022-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$69.00K derived: sum of 2 quarters · filed 2023-11-06 | -$73.00K 10-Q · filed 2023-11-06 | -$2.97M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$17.00K 10-Q · filed 2023-08-03 | -$2.91M derived: sum of 3 quarters · filed 2024-03-01 | -$8.50M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-03 | -$2.90M derived: sum of 2 quarters · filed 2024-03-01 | -$8.49M derived: sum of 3 quarters · filed 2024-03-01 | -$15.13M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2021-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$8.49M derived: sum of 2 quarters · filed 2024-03-01 | -$15.12M derived: sum of 3 quarters · filed 2024-03-01 | -$15.91M 10-K · filed 2024-03-01 | |
| 2021-09-30 | -$5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$12.23M derived: sum of 2 quarters · filed 2022-11-08 | -$13.02M 10-Q · filed 2022-11-08 | -$13.69M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | -$6.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$7.42M 10-Q · filed 2022-08-04 | -$8.10M derived: sum of 3 quarters · filed 2023-02-27 | -$8.79M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | -$790.00K 10-Q · filed 2022-05-09 | -$1.46M derived: sum of 2 quarters · filed 2023-02-27 | -$2.15M derived: sum of 3 quarters · filed 2023-02-27 | $3.27M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$1.36M derived: sum of 2 quarters · filed 2023-02-27 | $4.06M derived: sum of 3 quarters · filed 2023-02-27 | -$5.39M 10-K · filed 2023-02-27 | |
| 2020-09-30 | -$691.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $4.73M derived: sum of 2 quarters · filed 2021-10-28 | -$4.72M 10-Q · filed 2021-10-28 | -$17.16M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$4.03M 10-Q · filed 2021-07-29 | -$16.47M derived: sum of 3 quarters · filed 2022-03-01 | -$36.31M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$9.45M 10-Q · filed 2021-04-28 | -$21.89M derived: sum of 2 quarters · filed 2022-03-01 | -$41.74M derived: sum of 3 quarters · filed 2022-03-01 | -$60.68M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$12.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$32.29M derived: sum of 2 quarters · filed 2022-03-01 | -$51.23M derived: sum of 3 quarters · filed 2022-03-01 | -$69.30M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$19.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$38.79M derived: sum of 2 quarters · filed 2020-10-29 | -$56.86M 10-Q · filed 2020-10-29 | -$67.59M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-06-30 | -$18.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$37.02M 10-Q · filed 2020-07-31 | -$47.75M derived: sum of 3 quarters · filed 2021-02-18 | -$67.47M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-03-31 | -$18.07M 10-Q · filed 2020-05-06 | -$28.81M derived: sum of 2 quarters · filed 2021-02-18 | -$48.52M derived: sum of 3 quarters · filed 2021-02-18 | -$63.98M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2018-12-31 | -$10.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$30.45M derived: sum of 2 quarters · filed 2021-02-18 | -$45.91M derived: sum of 3 quarters · filed 2021-02-18 | -$61.26M 10-K · filed 2021-02-18 | |
| 2018-09-30 | -$19.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$35.17M derived: sum of 2 quarters · filed 2019-11-05 | -$50.53M 10-Q · filed 2019-11-05 | -$59.64M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$15.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$30.81M 10-Q · filed 2019-08-07 | -$39.92M derived: sum of 3 quarters · filed 2020-03-02 | -$58.57M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$15.36M 10-Q · filed 2019-05-08 | -$24.46M derived: sum of 2 quarters · filed 2020-03-02 | -$43.11M derived: sum of 3 quarters · filed 2020-03-02 | ||
| 2017-12-31 | -$9.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$27.75M derived: sum of 2 quarters · filed 2020-03-02 | -$58.88M 10-K · filed 2020-03-02 | ||
| 2017-09-30 | -$18.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$49.77M 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | -$31.12M 10-Q · filed 2018-08-07 | ||||
| 2016-12-31 | -$50.89M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |